Cargando…

Why Open Drug Discovery Needs Four Simple Rules for Licensing Data and Models

When we look at the rapid growth of scientific databases on the Internet in the past decade, we tend to take the accessibility and provenance of the data for granted. As we see a future of increased database integration, the licensing of the data may be a hurdle that hampers progress and usability....

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Antony J., Wilbanks, John, Ekins, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459841/
https://www.ncbi.nlm.nih.gov/pubmed/23028298
http://dx.doi.org/10.1371/journal.pcbi.1002706
Descripción
Sumario:When we look at the rapid growth of scientific databases on the Internet in the past decade, we tend to take the accessibility and provenance of the data for granted. As we see a future of increased database integration, the licensing of the data may be a hurdle that hampers progress and usability. We have formulated four rules for licensing data for open drug discovery, which we propose as a starting point for consideration by databases and for their ultimate adoption. This work could also be extended to the computational models derived from such data. We suggest that scientists in the future will need to consider data licensing before they embark upon re-using such content in databases they construct themselves.